These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 37057368)
21. Left ventricular function improvement after prophylactic implantable cardioverter-defibrillator implantation in patients with non-ischaemic dilated cardiomyopathy. Grimm W; Timmesfeld N; Efimova E Europace; 2013 Nov; 15(11):1594-600. PubMed ID: 23639855 [TBL] [Abstract][Full Text] [Related]
22. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Disertori M; Quintarelli S; Mazzola S; Favalli V; Narula N; Arbustini E Europace; 2013 Dec; 15(12):1693-701. PubMed ID: 23946316 [TBL] [Abstract][Full Text] [Related]
23. [Factors predisposing to the reprogramming of implantable cardioverter-defibrillators and the causes of changes in pharmacotherapy in patients with dilated cardiomyopathy for primary prevention of sudden cardiac death]. Pudło J; Liszniański P; Senderek T; Lelakowska-Pieła M; Lelakowski J; Nowak J Pol Merkur Lekarski; 2015 Aug; 39(230):86-90. PubMed ID: 26319381 [TBL] [Abstract][Full Text] [Related]
24. Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial. Rashba EJ; Estes NA; Wang P; Schaechter A; Howard A; Zareba W; Couderc JP; Perkiomaki J; Levine J; Kadish A Heart Rhythm; 2006 Mar; 3(3):281-6. PubMed ID: 16500299 [TBL] [Abstract][Full Text] [Related]
25. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT. Grimm W; Alter P; Maisch B Herz; 2004 May; 29(3):348-52. PubMed ID: 15167963 [TBL] [Abstract][Full Text] [Related]
26. Gender difference in arrhythmic occurrences in patients with nonischemic dilated cardiomyopathy and implantable cardioverter-defibrillator. Takahashi A; Shiga T; Shoda M; Tanizaki K; Manaka T; Ejima K; Kasanuki H; Hagiwara N Heart Vessels; 2010 Mar; 25(2):150-4. PubMed ID: 20339977 [TBL] [Abstract][Full Text] [Related]
27. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention. Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262 [TBL] [Abstract][Full Text] [Related]
28. Cardioverter-defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction. Jilek C; Lewalter T; Pauschinger M; von Scheidt W; Frankenstein L; Pfister O; Hambrecht R; Bruder O; Brachmann J; Hartmann A; Strasser R; Hochadel M; Senges J Clin Res Cardiol; 2020 Jan; 109(1):115-123. PubMed ID: 31236690 [TBL] [Abstract][Full Text] [Related]
29. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention. Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690 [TBL] [Abstract][Full Text] [Related]
30. Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: what have we learned and what can we expect from future trials? Grimm W Card Electrophysiol Rev; 2003 Dec; 7(4):463-7. PubMed ID: 15071276 [TBL] [Abstract][Full Text] [Related]
31. A Novel Risk Stratification Score for Sudden Cardiac Death Prediction in Middle-Aged, Nonischemic Dilated Cardiomyopathy Patients: The ESTIMATED Score. Li X; Fan X; Li S; Sun W; Shivkumar K; Zhao S; Lu M; Yao Y Can J Cardiol; 2020 Jul; 36(7):1121-1129. PubMed ID: 32249067 [TBL] [Abstract][Full Text] [Related]
32. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy. McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886 [TBL] [Abstract][Full Text] [Related]
33. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy. Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245 [TBL] [Abstract][Full Text] [Related]
34. Ventricular Arrhythmias and Sudden Death in Nonischemic Dilated Cardiomyopathy: Matter of Sex or Scar? Di-Marco A; Brown PF; Claver E; Bradley J; Nucifora G; Ruiz-Cueto M; Dallaglio PD; Rodriguez M; Comin-Colet J; Anguera I; Miller CA; Schmitt M J Card Fail; 2022 Aug; 28(8):1278-1286. PubMed ID: 35176484 [TBL] [Abstract][Full Text] [Related]
35. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?". Zecchin M; Merlo M; Pivetta A; Barbati G; Lutman C; Gregori D; Serdoz LV; Bardari S; Magnani S; Di Lenarda A; Proclemer A; Sinagra G Am J Cardiol; 2012 Mar; 109(5):729-35. PubMed ID: 22176998 [TBL] [Abstract][Full Text] [Related]
36. The prognostic role of late gadolinium enhancement on cardiac magnetic resonance in patients with nonischemic cardiomyopathy and reduced ejection fraction, implanted with cardioverter defibrillators for primary prevention. A systematic review and meta-analysis. Anagnostopoulos I; Kousta M; Kossyvakis C; Lakka E; Paraskevaidis NT; Schizas N; Alexopoulos N; Deftereos S; Giannopoulos G J Interv Card Electrophysiol; 2022 Apr; 63(3):523-530. PubMed ID: 34218421 [TBL] [Abstract][Full Text] [Related]
37. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients. Jukema JW; Timal RJ; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Zwinderman AH; van Erven L; Krol-van Straaten MJ; Hommes N; Gabreëls B; van Dorp W; van Dam B; Herzog CA; Schalij MJ; Rabelink TJ; Circulation; 2019 Jun; 139(23):2628-2638. PubMed ID: 30882234 [TBL] [Abstract][Full Text] [Related]
38. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. Fonarow GC; Feliciano Z; Boyle NG; Knight L; Woo MA; Moriguchi JD; Laks H; Wiener I Am J Cardiol; 2000 Apr; 85(8):981-5. PubMed ID: 10760339 [TBL] [Abstract][Full Text] [Related]
39. Left Atrial Function Using Cardiovascular Magnetic Resonance Imaging Independently Predicts Life-Threatening Arrhythmias in Patients Referred to Receive a Primary Prevention Implantable Cardioverter Defibrillator. Lydell CP; Mikami Y; Homer K; Peng M; Cornhill A; Rajagopalan A; Arasaratnam P; Cowan K; Roberts A; Sumner C; Heydari B; Howarth AG; Exner D; White JA Can J Cardiol; 2019 Sep; 35(9):1149-1157. PubMed ID: 31472813 [TBL] [Abstract][Full Text] [Related]
40. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A; Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]